Financhill
Back

AbbVie, Inc. Vs. Structure Therapeutics, Inc. Industry Stock Comparison

Buy
59

ABBV
AbbVie, Inc.

Last Price:
$230.19
Seasonality Move:
3.6%
Buy
63

GPCR
Structure Therapeutics, Inc.

Last Price:
$69.33
Seasonality Move:
-34.19%
Buy
59
AbbVie, Inc. (ABBV) is a Buy

Is AbbVie, Inc. a Buy, Sell or Hold?

  • The current AbbVie, Inc. [ABBV] share price is $228.79. The Score for ABBV is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • ABBV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Structure Therapeutics, Inc. [GPCR] share price is $71.29. The Score for GPCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ABBV Stock Price Chart

What is AbbVie, Inc.'s stock price today?

  • The AbbVie, Inc. share price today is $228.79
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ABBV is experiencing slight selling pressure.

GPCR Stock Price Chart

What is Structure Therapeutics, Inc.'s stock price today?

  • The Structure Therapeutics, Inc. share price today is $71.29
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

ABBV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.16 Sell
Relative Strength Index (14 RSI): 54.18 Buy
Chaikin Money Flow: -1404753 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (223.76 - 230.96) Buy
Bollinger Bands (100): (210.27 - 231.57) Buy

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.5 Buy
Relative Strength Index (14 RSI): 72.85 Buy
Chaikin Money Flow: 1903413 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.41 - 65.27) Buy
Bollinger Bands (100): (17 - 45.24) Buy

ABBV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 225.64 Buy
20-day SMA: 226.1 Buy
50-day SMA: 226.59 Buy
200-day SMA: 205.63 Buy
8-day EMA: 226.33 Buy
20-day EMA: 226.27 Buy
50-day EMA: 225.21 Buy
200-day EMA: 209.64 Buy

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.43 Buy
20-day SMA: 52.92 Buy
50-day SMA: 40.28 Buy
200-day SMA: 26.09 Buy
8-day EMA: 64 Buy
20-day EMA: 55.88 Buy
50-day EMA: 44.22 Buy
200-day EMA: 31.26 Buy

AbbVie, Inc. Earnings Growth & ABBV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.47 per share, and an increase next year of $3.61 per share.

Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.10 per share.

AbbVie, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Structure Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):